Dr. Reddy’s launches generic Proscar and Zocor in US
Andhracafe: One of India’s largest pharmaceutical companies, Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) recently launched the generic versions of Merck & Co’s prostate cancer drug Proscar and Zocor in the US market after the expiry of Merck’s patents. Zocor is used to reduce cholesterol while Proscar is used to treat benign prostatic hyperplasia. Dr Reddy’s lab will be allowed to sell the generic version of drug’s Zocor and Proscar
This is certainly positive for the Dr. Reddy’s Lab , recent regulatory and much awaited patent law changes have lead the Indian Pharmaceutical Industry towards exploring newer avenues of drug development, thus, promising higher capital investment in the pharmaceutical industry in the near future. Companies like Dr Reddy and Ranbaxy are constantly moving further in revenue chain by improving their R&D and cutting cost. Strong government support and availability of surplus skilled technical workers at lower costs has helped them a lot.